Analyst firms · H.C. Wainwright · REPL
H.C. Wainwright REPL price target and rating history
Replimune Group Inc. (REPL) · Health Care
H.C. Wainwright rates Replimune Group Inc. (REPL) Sell with a $12 price target, as of its latest action on Apr 13, 2026. It has published 3 rating actions on REPL since July 2025, including 1 upgrade and 2 downgrades. Across 5 firms with a REPL price target in the last 12 months, the median target is $12.
- Current rating
- Sell
- Price target
- $12
- Median target, all firms
- $12
- Actions on REPL
- 3
Every H.C. Wainwright rating on REPL
- Apr 13, 2026
- Oct 27, 2025
- Jul 23, 2025
How other firms rate REPL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wedbush | Outperform | $12 | Aug 7, 2026 |
| Leerink Partners | Outperform | $17 | Aug 4, 2026 |
| Cantor Fitzgerald | Overweight | Jul 31, 2026 | |
| BMO Capital Markets | Outperform | $16 | Jun 30, 2026 |
| Jefferies | Hold | $2 | Apr 13, 2026 |
| H.C. Wainwright | Sell | Apr 13, 2026 | |
| Piper Sandler | Neutral | $4 | Apr 10, 2026 |
Questions about H.C. Wainwright and REPL
- What is H.C. Wainwright's price target for REPL?
- H.C. Wainwright's latest stated price target for Replimune Group Inc. (REPL) is $12, from its action on Oct 27, 2025.
- What is H.C. Wainwright's rating on REPL?
- H.C. Wainwright rates REPL Sell, a bearish rating, as of Apr 13, 2026.
- When did H.C. Wainwright last change its view on REPL?
- On Apr 13, 2026, H.C. Wainwright downgrades to Sell from Buy.
- How does H.C. Wainwright's REPL target compare with other analysts?
- Across 5 firms with a REPL price target in the last 12 months, the median target is $12.
More REPL rating histories
All H.C. Wainwright ratingsREPL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.